查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1775454

管瓶市場：2025 年至 2030 年預測

Vials Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 144 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計管瓶市場規模將從 2025 年的 120.58 億美元成長至 2030 年的 159.15 億美元，複合年成長率為 5.71%。

生物技術進步與投資

生物技術仍是管瓶市場的基石，其應用領域涵蓋製藥、農業和分子美食。大量投資正在推動該領域的研發，推動了對作為實驗室必需部件的管瓶的需求。例如，2024年，ARCH Venture Partners 撥出大量資金支持生物技術創新，支持了 Vir Biotechnology、Alnylam Pharmaceuticals、VBI Vaccines、Brii Biosciences 和 Sana Biotechnology 等專注於先進療法（包括 COVID-19 治療）的公司。 Quantalix 正在開發臨床檢測技術，而 Twist Biosciences 正在開發用於治療和疫苗開發的基因編輯工具。 Bellerophon 的吸入式一氧化氮輸送系統於 2023 年獲得美國食品藥物管理局 (FDA) 的緊急使用核准，可緩解 COVID-19 患者的呼吸窘迫。 Conagen 致力於永續綠色化學品的合成生物學研發工作，進一步體現了對環保解決方案的追求。在解決全球健康和環境問題的需要的推動下，這些投資預計將增加對管瓶的需求，小瓶對於在研發和生產過程中儲存和處理敏感生物材料至關重要。

政府支持政策

政府的優惠政策鼓勵生物技術及相關領域的影響力投資和研發，進而促進市場成長。例如，歐盟（EU）的目標是到2025年將GDP的3.5%用於研發支出，以促進創新，如聯邦研究與創新資助諮詢服務中心所述。在印度，生物技術部（DBT）和印度醫學研究理事會（ICMR）制定了“國家幹細胞治療指南”，建議到2024年資助47個合作計劃。這些措施正在推動生物技術研究，並增加了實驗室對用於樣本儲存、測試和開發的管瓶的需求。此類政府支持將維持科研必需管瓶的需求，並在預測期內推動市場擴張。

個人護理和營養補充劑的成長

另一個關鍵促進因素是個人保健產品和營養補充劑的需求不斷成長，尤其是在注重健康的都市區消費者群體中。可支配收入的增加促使消費者偏好高階產品，例如基於植物化學成分的營養補充劑和不含有害化學物質的潔淨標示護膚。這一趨勢正推動市場參與者擴大其創新健康產品陣容，使得管瓶在產品開發和零售包裝中成為必要。例如，管瓶可用於在研發過程中儲存活性成分，並作為高階個人保健產品（如精華液和精油）的高階包裝。日益成長的城市人口重視健康和永續性，這進一步擴大了這一需求，並推動了管瓶市場的發展。

區域洞察

北美市場佔有率，這得益於其在生物技術領域的大量投資、先進的醫療基礎設施以及消費者在個人護理和營養補充劑方面的高支出。美國尤其受益於其強大的研發生態系統和對生物技術進步的監管支持。亞太地區是成長最快的市場，這得益於都市化加快、可支配收入增加以及印度和中國等國政府為加強生物技術和醫療保健產業所採取的舉措。歐洲也因其強力的政策框架支持研發和永續產品開發而成為主要貢獻者。

市場挑戰

管瓶市場面臨與供應鏈限制和原料成本相關的挑戰，尤其是在生物技術和製藥領域所需的高品質玻璃和塑膠管瓶方面。此外，管瓶設計和材料也需要持續創新，以確保其適用於從無菌藥物儲存到消費者個人保健產品等各種應用。醫療和食品應用中使用的管瓶的合規性也增加了複雜性，並可能增加製造成本。

結論

預計到2028年，管瓶市場將迎來強勁成長，這得益於生物技術的進步、政府的支持政策以及個人護理和營養補充劑需求的不斷成長。研發投入，尤其是在北美和亞太地區，正在推動實驗室和產品開發對管瓶的需求。消費品朝向高階化和健康化方向的轉變，進一步推動了包裝應用對管瓶的需求。然而，供應鏈約束和法規遵從性等挑戰需要策略性解決方案來維持市場動能。產業參與者必須專注於技術創新和擴充性，才能抓住這些成長機會。

本報告的主要優點

  • 深刻分析：獲得涵蓋主要地區和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
  • 競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議：利用洞察力進行策略決策並在動態環境中開闢新的業務流和收益。
  • 適合廣泛的使用者：對於新興企業、研究機構、顧問、中小企業和大型企業來說都是有益且具有成本效益的。

它有什麼用途？

產業和市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

  • 2022 年至 2024 年的歷史數據和 2025 年至 2030 年的預測數據
  • 成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 收益成長和預測細分市場和區域分析（包括國家）
  • 公司概況（尤其是財務狀況和關鍵發展）

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 研究範圍
  • 市場區隔

第3章 經營狀況

  • 市場促進因素
  • 市場限制
  • 市場機會
  • 波特五力分析
  • 產業價值鏈分析
  • 政策法規
  • 策略建議

第4章 技術展望

第5章管瓶市場（依容量）

  • 介紹
  • 最大2毫升
  • 3ml～5ml
  • 5ml～7ml
  • 8毫升或更多

第6章管瓶瓶市場（依材質）

  • 介紹
  • 玻璃
    • 硼硼矽酸玻璃
    • 熔融石英
  • 聚合物
  • 塑膠
    • 熱塑性塑膠
      • HDPE
      • 聚氯乙烯
      • 聚碳酸酯
      • 聚丙烯
    • 熱固性樹脂
      • 三聚氰胺甲醛
      • 苯酚甲醛
      • 聚脲甲醛
      • 其他

第7章管瓶市場：依灌裝技術

  • 介紹
  • 淨重填料
  • 旋轉包裝
  • 體積填充劑
  • 其他填充劑

第 8 章管瓶市場（依最終用戶）

  • 介紹
  • 個人護理
  • 化學品
  • 衛生保健
  • 醫院
  • 製藥
  • 研究辦公室

第9章管瓶瓶市場（按地區）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 台灣
    • 泰國
    • 其他

第10章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第11章 公司簡介

  • Amcor plc
  • Gerresheimer AG
  • SCHOTT AG
  • West Pharmaceutical Services, Inc.
  • Becton, Dickinson and Company
  • AptarGroup, Inc.
  • Corning Incorporated

第12章 附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061613493

The Vials Market is expected to grow from USD 12.058 billion in 2025 to USD 15.915 billion in 2030, at a CAGR of 5.71%.

Biotechnology Advancements and Investments

Biotechnology remains a cornerstone of the vials market, with its applications spanning pharmaceuticals, agriculture, and molecular gastronomy. Significant investments are fueling research and development (R&D) in this sector, increasing the demand for vials as essential laboratory components. For instance, in 2024, ARCH Venture Partners allocated substantial funding to support biotech innovation, backing companies like Vir Biotechnology, Alnylam Pharmaceuticals, VBI Vaccines, Brii Biosciences, and Sana Biotechnology, which focus on advanced therapeutics, including COVID-19 treatments. Quanterix is advancing clinical testing technologies, while Twist Biosciences develops gene-editing tools for therapeutic and vaccine development. Bellerophon's inhaled nitric oxide delivery systems, approved for emergency use by the FDA in 2023, address respiratory distress in COVID-19 patients. Conagen's synthetic biology R&D, aimed at sustainable green chemicals, further exemplifies the push for eco-friendly solutions. These investments, driven by the need to address global health and environmental challenges, are expected to heighten the demand for vials, which are critical for storing and handling sensitive biological materials during R&D and production processes.

Supportive Government Policies

Favorable government policies are catalyzing market growth by promoting impact investments and R&D in biotechnology and related fields. For example, in 2025, the European Union targeted 3.5% of GDP for R&D spending to foster innovation, as outlined by the Federal Funding Advisory Service for Research and Innovation. In India, the Department of Biotechnology (DBT) and the Indian Council of Medical Research (ICMR) are formulating the "National Guidelines for Stem Cell Therapy," with 47 collaborative projects recommended for funding in 2024. These initiatives enhance biotechnological research, increasing the need for vials in laboratories for sample storage, testing, and development. Such government-backed efforts ensure sustained demand for vials as an indispensable component of scientific research, driving market expansion over the forecast period.

Growth in Personal Care and Nutraceuticals

The rising demand for personal care products and nutraceuticals, particularly among health-conscious urban consumers, is another key driver. Increasing disposable incomes have shifted consumer preferences toward premium and luxury products, including phytochemical-based nutraceuticals and clean-label skincare free of harmful chemicals. This trend has prompted market players to expand their product portfolios to include innovative, health-focused offerings, necessitating vials for both product development and retail packaging. For instance, vials are used to store active ingredients during R&D and as premium packaging for high-end personal care products, such as serums and essential oils. The growing urban population's focus on wellness and sustainability further amplifies this demand, propelling the vials market.

Regional Insights

North America holds a significant market share, driven by substantial biotech investments, advanced healthcare infrastructure, and high consumer spending on personal care and nutraceuticals. The United States, in particular, benefits from robust R&D ecosystems and regulatory support for biotechnological advancements. The Asia-Pacific region is the fastest-growing market, fueled by increasing urbanization, rising disposable incomes, and government initiatives in countries like India and China to bolster biotech and healthcare sectors. Europe also contributes significantly, with strong policy frameworks supporting R&D and sustainable product development.

Market Challenges

The vials market faces challenges related to supply chain constraints and raw material costs, particularly for high-quality glass and plastic vials required in biotechnology and pharmaceuticals. Additionally, ensuring compatibility with diverse applications, from sterile pharmaceutical storage to consumer-facing personal care products, requires ongoing innovation in vial design and materials. Regulatory compliance for vials used in medical and food applications also adds complexity, potentially increasing production costs.

Conclusion

The vials market is set for robust growth through 2028, driven by biotechnology advancements, supportive government policies, and rising demand for personal care and nutraceutical products. Investments in R&D, particularly in North America and Asia-Pacific, are increasing the need for vials in laboratories and product development. The shift toward premium, health-focused consumer goods further boosts demand for vials in packaging applications. However, challenges like supply chain constraints and regulatory compliance require strategic solutions to sustain market momentum. Industry players must focus on innovation and scalability to capitalize on these growth opportunities.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Capacity

  • Up to 2 ml
  • 3 ml - 5 ml
  • 5 ml - 7 ml
  • 8 ml and above

By Material

  • Glass
  • Borosilicate glass
  • Fused Silica
  • Polymer
  • Plastic
  • Thermoplastics
  • HDPE
  • Poly Vinyl Chloride
  • Polycarbonate
  • Polypropylene
  • Thermosets
  • Melamine Formaldehyde
  • Phenol Formaldehyde
  • PolyUrea Formaldehyde
  • Others

By Filling Technology

  • Net weight fillers
  • Rotary fillers
  • Volumetric fillers
  • Other fillers

By End User

  • Personal Care
  • Chemicals
  • Healthcare
  • Hospitals
  • Pharmaceuticals
  • Research Laboratories

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. VIALS MARKET BY CAPACITY

  • 5.1. Introduction
  • 5.2. Up to 2 ml
  • 5.3. 3 ml - 5 ml
  • 5.4. 5 ml - 7 ml
  • 5.5. 8 ml and above

6. VIALS MARKET BY MATERIAL

  • 6.1. Introduction
  • 6.2. Glass
    • 6.2.1. Borosilicate glass
    • 6.2.2. Fused Silica
  • 6.3. Polymer
  • 6.4. Plastic
    • 6.5.1. Thermoplastics
      • 6.5.1.1. HDPE
      • 6.5.1.2. Poly Vinyl Chloride
      • 6.5.1.3. Polycarbonate
      • 6.5.1.4. Polypropylene
    • 6.5.2. Thermosets
      • 6.5.2.1. Melamine Formaldehyde
      • 6.5.2.2. Phenol Formaldehyde
      • 6.5.2.3. PolyUrea Formaldehyde
      • 6.5.2.4. Others

7. VIALS MARKET BY FILLING TECHNOLOGY

  • 7.1. Introduction
  • 7.2. Net weight fillers
  • 7.3. Rotary fillers
  • 7.4. Volumetric fillers
  • 7.5. Other fillers

8. VIALS MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Personal Care
  • 8.3. Chemicals
  • 8.4. Healthcare
  • 8.5. Hospitals
  • 8.6. Pharmaceuticals
  • 8.7. Research Laboratories

9. VIALS MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Italy
    • 9.4.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. Taiwan
    • 9.6.5. Thailand
    • 9.6.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Amcor plc
  • 11.2. Gerresheimer AG
  • 11.3. SCHOTT AG
  • 11.4. West Pharmaceutical Services, Inc.
  • 11.5. Becton, Dickinson and Company
  • 11.6. AptarGroup, Inc.
  • 11.7 Corning Incorporated

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key benefits for the stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations